"Chiesi Pharmaceuticals has been operating in human health within the pharmaceutical sector since 2007 as the established R&D-focused Chiesi Group's embedded operation in Turkey. Chiesi Pharmaceuticals has a broad portfolio of products based on innovative pharmaceutical technology in areas for respiration, allergy, neonatal, hereditary, cardiovascular diseases, and pain/inflammation treatments."

"Chiesi is the largest global pharmaceutical group to be awarded B Corp Certification, a recognition of high social and environmental standards. It is an achievement to be proud of, and yet one that feels natural: caring for others lies at the root of health science and has always been at the heart of our work."